Find link

language:

Find link is a tool written by Edward Betts.

Longer titles found: MedImmune, Inc. v. Genentech, Inc. (view)

searching for MedImmune 24 found (156 total)

alternate case: medImmune

Moxetumomab pasudotox (1,437 words) [view diff] exact match in snippet view article find links to article

acquired by AstraZeneca, who also acquired MedImmune, combining the two into a biologics division. MedImmune renamed CAT-8015 to moxetumomab pasudotox

Anti-CD22 immunotoxin (848 words) [view diff] exact match in snippet view article find links to article

the National Cancer Institute. The patent holder is MedImmune, a subsidiary of AstraZeneca. MedImmune discontinued development of CAT-3888 in 2008 and continues

Briakinumab (551 words) [view diff] exact match in snippet view article find links to article

com. Archived from the original on 2010-07-31. Retrieved 2010-05-12. "MedImmune: External R&D Partnering". Archived from the original on 2013-04-28. Retrieved

CD22 (1,761 words) [view diff] case mismatch in snippet view article find links to article

pdf Archived 2007-02-27 at the Wayback Machine CAT URL Redirects to Medimmune home page "Lumoxiti EPAR". European Medicines Agency (EMA). 9 December

Jeong H. Kim (2,850 words) [view diff] exact match in snippet view article find links to article

on 3 July 2013. Retrieved 9 May 2016. Guidera, Mark (17 April 1998). "MedImmune named Md. high tech firm of year Other winners were Kim of Yuri Systems

Dek Woolfson (1,309 words) [view diff] case mismatch in snippet view article find links to article

assembly, prediction, modelling and design of coiled-coil proteins. 2011 – Medimmune Protein and Peptide Science Award of the Royal Society of Chemistry. 2014

Retrogenix (792 words) [view diff] case mismatch in snippet view article find links to article

been selected through phenotypic screening. Notably, in studies led by Medimmune, the technology identified disease-relevant cell surface antigens of promising

Gregory Prince (2,064 words) [view diff] exact match in snippet view article find links to article

pneumonia throughout the world.) VSI's technologies were licensed to MedImmune, Inc., and the collaborative efforts of the two companies and other partners

Checkpoint inhibitor (2,093 words) [view diff] case mismatch in snippet view article find links to article

carcinoma, urothelial carcinoma, renal cell carcinoma Durvalumab Imfinzi Medimmune/AstraZeneca PD-L1 2017 non-small cell lung cancer, small cell lung cancer

Neutralizing antibody (3,495 words) [view diff] case mismatch in snippet view article find links to article

1056/NEJMoa1604330. PMC 5086427. PMID 27732819. "Label - Palivizumab (Synagis), Medimmune, Incorporated" (PDF). Retrieved 4 February 2020. VanBlargan, Laura A.;

William E. Bentley (627 words) [view diff] exact match in snippet view article find links to article

associated with the BSF, the facility performed contract research projects for MedImmune (Synagis) and Martek (Life's DHA) Distinguished University Professor (UMD)

Tim Calkins (professor) (788 words) [view diff] exact match in snippet view article

has published more than a dozen Kellogg case studies including Crestor, MedImmune: FluMist Introduction and Genzyme: the Synvisc-One Investment Decision

List of human clusters of differentiation (467 words) [view diff] case mismatch in snippet view article find links to article

rather than blockade of the OX40 signaling pathway upon receptor binding; Medimmune AstraZeneca is developing 3 drugs targeting OX40 in colorectal, prostate

Jawahar L. Mehta (1,198 words) [view diff] exact match in snippet view article find links to article

therapeutic targets now being pursued by several biotech companies, such as MedImmune. He is a member of the American Society for Clinical Investigation, American

Greater Washington Partnership (2,107 words) [view diff] exact match in snippet view article find links to article

require. CoLAB companies include Amazon, Capital One, JPMorgan Chase, MedImmune, Monumental Sports & Entertainment, Northrop Grumman, and Under Armour

Ashok Venkitaraman (1,462 words) [view diff] exact match in snippet view article find links to article

companies such as Astex Therapeutics and Cambridge Antibody Technology/MedImmune, he currently holds appointments with Sentinel Oncology and PhoreMost

G1 Therapeutics (2,065 words) [view diff] exact match in snippet view article find links to article

Inc. Other early investors included AstraZeneca’s venture capital fund MedImmune Ventures, and Cormorant Asset Management. G1 went public on May 17, 2017

List of United States Supreme Court cases by the Roberts Court (401 words) [view diff] case mismatch in snippet view article find links to article

under 28 U.S.C. § 2415 is not applicable to administrative proceedings Medimmune, Inc. v. Genentech, Inc. 549 U.S. 118 (2007) enforceability of patents

2009 swine flu pandemic vaccine (9,963 words) [view diff] exact match in snippet view article find links to article

Retrieved 16 October 2019. "Influenza A (H1N1) 2009 Monovalent Vaccine (MedImmune LLC)]". U.S. Food and Drug Administration (FDA). Archived from the original

2019 Birthday Honours (20,719 words) [view diff] exact match in snippet view article find links to article

Jane Katharine Osbourn – Vice President for Research and Development, MedImmune Biotechnology and chair, UK Bioindustry Association. For services to Drug

2019 Birthday Honours (20,719 words) [view diff] exact match in snippet view article find links to article

Jane Katharine Osbourn – Vice President for Research and Development, MedImmune Biotechnology and chair, UK Bioindustry Association. For services to Drug

Henri Termeer (5,087 words) [view diff] exact match in snippet view article find links to article

David Mott, General Partner of NEA and formerly a key executive with MedImmune to the Supervisory Board. Also added to this Supervisory Board in recent

Specialty drugs in the United States (9,033 words) [view diff] exact match in snippet view article find links to article

was acquired by Walgreens in 2012. Specialty companies like Genzyme and MedImmune were acquired and are transitioning to a new business model.: 12 According

Impression Prods., Inc. v. Lexmark Int'l, Inc. (7,947 words) [view diff] exact match in snippet view article find links to article

(2006); Global–Tech Appliances, Inc. v. SEB S.A., 563 U.S. 754 (2011); MedImmune, Inc. v. Genentech, Inc., 549 U.S. 118, 132 n. 11 (2007). Under German